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Regulation of human ovarian steroidogenesis differs from other species and precise 
knowledge on how human small antral follicles (hSAF) develop and acquire competence for 
continued growth and steroid output is still incomplete. The present study has characterized 
almost 1,000 normal hSAF collected in connection with cryopreservation of ovarian tissue 
for fertility preservation. The antral follicles (ranging from 3 to 13 mm) were generally aspi-
rated from one ovary surgically removed during the natural cycle, and the follicular fluid (FF) 
and the granulosa cells (GC) were isolated and snap-frozen. In FF, the following hormones 
were measured: inhibin-B, inhibin-A, AMH, follistatin, PAPP-A, estradiol, progesterone, 
testosterone, and androstenedione. In GC, mRNA gene expressions using q-PCR were 
measured for the following genes: FSHR, AMH, CYP19, and AR. All samples in which one 
of the abovementioned parameters was measured were included, but typically multiple 
parameters were measured. Highly significant differences in concentration and follicular 
content in relation to follicular diameter were found for all measured hormones despite 
massive variability in-between follicles for any given diameter. The results demonstrate that 
profound changes take place in the hormonal microenvironment around follicular diameters 
of 8–11 mm corresponding to when follicular selection occurs. At this point, inhibin-B and 
inhibin-A showed distinct peaks concomitant with a significant reduction in both AMH 
protein and mRNA expression. Concentrations of inhibins, androgens, FSHR, and AR 
were intimately associated, and it is suggested that inhibin-B in combination with PAPP-A 
and thereby IGF2 activity exerts important paracrine signaling at follicular selection. At the 
same time upregulation of estradiol synthesis and CYP19 mRNA expression increased 
steroid output profoundly. Furthermore, the highly significant association between FSHR 
and AR mRNA gene expression enforces important functions of androgens in follicular 
development. Collectively, these data reintroduce the understanding of the follicular phase 
as two parted in which regulation of steroidogenesis differs. The profound changes taking 
place around follicular selection highlight important paracrine actions of TGF-β family 
members and IGFs for securing dominance of the selected follicle.
Keywords: human ovarian steroidogenesis, human small antral follicles, follicle-stimulating hormone, 
luteinizing hormone, granulosa cells, follicular fluid, inhibin-B, paracrine signaling
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inTrODUcTiOn
Follicles are the functional units of the ovaries. Each follicle 
consists of a single oocyte surrounded by somatic granulosa 
cells (GC) covering the internal surface of the basal membrane 
that encompasses follicles and prevents vessels from entering. 
Early in development, follicles recruit theca cells immediately 
adjacent to the basal membrane encircling the follicle. The theca 
cells become highly vascularized and secure transport of hor-
mones including gonadotrophins to and from both the follicle 
and the theca cells. When human follicles reach a diameter of 
around 200–300  µm a fluid-filled antral cavity starts to form, 
which contains the follicular fluid (FF). The FF consists of filtra-
tions or transudates from circulation that penetrate the basal 
membrane and of GC secretions including a number of steroid 
and peptide hormones (1). The composition of hormones 
in FF is very dynamic in relation to developmental stage and 
very different from conditions found in circulation (2–4). For 
instance, steroidogenesis is very prominent throughout most of 
follicular development with synthesis of androgens in the theca 
cells by stimulation with luteinizing hormone (LH), which to 
a high degree is converted to estrogens in GC via stimulation 
with follicle-stimulating hormone (FSH), illustrating the two-
cell, two-gonadotropin concept. As the follicle matures, the 
concentration of steroids such as estradiol and progesterone 
increases and reaches levels 1–10,000-fold higher than in cir-
culation. In addition, several peptide hormones are specifically 
synthesized by the GC including AMH, inhibin-A, and inhibin-
B. They also accumulate in FF often with concentrations more 
than 1,000 times higher than in circulation (4, 5). Growth and 
development of human small antral follicles (hSAF) are affected 
by these and other hormones, and a number of both autocrine 
and paracrine effects are dependent on the very different and 
local concentrations present in FF and in theca cells (6–8). 
It has been suggested that inhibin-B in addition to attenuate 
pituitary FSH secretion also plays an important paracrine effect 
in augmenting theca cell androgen production in synergy with 
LH (9–12). These fine-tuned local mechanisms are likely to exert 
an important function in the process of selecting the dominant 
follicle that takes place in each individual menstrual cycle (5). 
Almost four decades ago, it was realized that each individual 
follicle possesses a unique hormonal fingerprint and that the 
microenvironment in the follicle to a large extent determines 
its further developmental capacity (13). Furthermore, the 
dynamic changes in FF in relation to the developmental stage 
of the human follicles are massive, probably reflecting the vari-
able hormonal and nutritional requirement of the developing 
follicle and the enclosed oocyte (14). Although FF from large 
preovulatory follicles, especially as collected in connection 
with IVF treatment, has received a lot of attention scientifically, 
normal hSAF have only to a limited degree been studied mainly 
because of unavailability. However, this has changed in recent 
years because women in connection with fertility preservation 
often have one entire ovary excised for cryopreservation (15). 
The hSAF do not sustain freezing and are normally discarded. 
During the last 10 years, we have accumulated a large number 
of hSAF including FF and corresponding GC.
The aim of the present study was to characterize the hallmarks 
of hormonal and genetic markers of normal hSAF, spanning in fol-
licular diameter from 3 to 13 mm. This cohort of follicles thereby 
constitutes the follicular starting point for ovarian stimulation 
with exogenous hormones as used in connection with infertility 
treatment.
MaTerials anD MeThODs
All follicles were collected from surplus ovarian tissue from women 
undergoing fertility preservation, having ovarian tissue cryopre-
served at the Laboratory of Reproductive Biology, Rigshospitalet, 
Denmark. The fertility preservation procedure normally involved 
excision of one entire ovary from which individual visible antral 
follicles were aspirated with a 23G needle attached to a syringe. 
The fluid was centrifuged, the FF aspirated and immediately 
stored at −80°C or snap frozen in liquid nitrogen. The diameter 
of the follicles was calculated based on the aspirated volume. In 
some cases, the GC was also collected and snap frozen in liquid 
nitrogen.
Collection of follicles has taken place during the last 15 years, 
and parts of the present material of both FF and GC have been 
used in several individual studies (16–26). Included in the pre-
sent study is any follicle on which at least one of the reported 
parameters has been measured. Excluded from the analysis are 
girls below the age of 16 years and those who had a diagnosis for 
fertility preservation that included a disease of the ovary (e.g., 
ovarian cancer). The diagnoses of the women included were as 
follows: cancer mammae: 133; Md. Hodgkin: 41; non-Hodgkin 
and other lymphoma: 20; Ewing sarcoma and other sarcoma: 
14; cervix: 13; leukemia: 13; cancer cerebrum: 12; colon cancer: 
7; autoimmune diseases: 5; others: 28. The collection of FF had 
no effect on the fertility preservation procedure. In all cases, the 
ovary had overall gross normal appearance.
In total, 958 follicles were collected from 286 women, with a 
mean age of 28 years (ranging from 16 to 43 years). The number 
of follicles collected from each woman ranged from 1 to 13 (mean 
3.3 follicles/patient; median 3.0). The number of women in rela-
tion to the number of follicles aspirated is given in Figure 1A. 
Follicle diameters ranged from 3 to 13 mm, as calculated from the 
aspirated volume, assuming a spherical structure of the follicle. 
The frequency of follicles aspirated with a specific diameter (e.g., 
5 mm follicles compromise follicles with 4.5–5.5 mm in diameter) 
from the cohort of follicles is depicted in Figure 1B.
The hormone milieu in hSAF has been shown to be independ-
ent of circulating levels of gonadotropins and has no major impact 
on the serum hormone levels, thus serum hormone levels were 
not included in this study (22, 26, 27). The follicles were collected 
at various times during the menstrual cycle, as the hormone 
levels of hSAF remain constant throughout the menstrual cycle 
(23, 27, 28).
hormone Measurements
The concentrations of AMH, inhibin-A, and inhibin-B were 
measured using commercially available ELISA assays. AMH 
was measured using the Ultra-Sensitive AMH/MIS ELISA kit 
(Al-105-i, Ansh Labs, Webster, TX, USA), Inhibin-A ELISA kit 
FigUre 1 | Number and diameter of follicles collected per woman. (a) Bars depict the frequency of small antral follicles in relation to the specific diameters.  
(B) Bars depict the number of small antral follicles collected per woman.
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(AL-123-i, Ansh Labs, Webster, TX, USA), and Inhibin-B ELISA 
kit (AL-107-i Ansh Labs, Webster, TX, USA) according to the 
manufacturer’s protocol, with an appropriate dilution of the FF 
samples using the supplied assay buffer. Estradiol, progesterone, 
androstenedione, and testosterone were initially measured using 
commercially available RIA kits (DSL-43100, DSL-3400, DSL-
3800, and DSL-4000; DSL, Webster, TX, USA). However, during 
the course of sample collection, the RIA assays became unavail-
able, and it was necessary to switch to ELISA assays (NovaTec 
Immundiagnostica, Dietzenbach, Germany, DNOV 002, 003, 
006, and 008, respectively). Due to limited sample material, it 
was not possible to reanalyze the FF with ELISA kits. Based on 
highly significant linear correlations between the results from the 
two types of assays (correlation coefficients: estradiol r =  0.99, 
progesterone r = 0.93, testosterone r = 0.91, and androstenedione 
r = 0.91), mathematical conversion of values to the ELISA stand-
ard was performed as previously published (21). The remaining 
follicles were analyzed using NovaTec ELISA assays, according to 
the manufacturer’s protocol, using in-house prepared steroid-free 
serum for FF dilution.
rna Purification
From individual GC samples, total RNA was purified using a 
combination of Tri Reagent (Sigma-Aldrich, St. Louis, MO, USA) 
and the RNeasy Mini Kit (Qiagen, Hilden, Germany). For each 
sample, the quality of the purified RNA was analyzed using an 
Agilent 2100 Bioanalyzer and an RNA 6000 Pico LabChip (RNA 
6000 Pico assay kit, Agilent Technologies, Waldbronn, Germany). 
The RNA integrity number should be higher than the internal 
threshold value in order to qualify samples for the study. Total 
RNA quantity in each sample was measured using a Beckman 
Coulter Du730 life science UV/vis spectrophotometer.
cDna synthesis and qPcr analysis
First-strand cDNA was synthesized using the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, 
CA, USA). Briefly, a master mix containing 2.0 µl 10× RT Buffer, 
0.8 µL 25× dNTP Mix (100 mM), 2.0 µl 10× RT Random Primers, 
1.0 µl MultiScribe™ Reverse Transcriptase (50 U/μl), 0.5 µl RNase 
inhibitor, and 4.7 µl nuclease-free (DEPC) water was prepared for 
each 20 µl reaction. 11 µl master mix was added to 9 µl of total 
RNA. Samples were centrifuged briefly at 12,000 × g and then 
incubated at room temperature for 10 min, followed by 37°C for 
2 h and finally, 85°C for 5 s.
Gene expression levels were evaluated by relative quanti-
fication-PCR analysis using TaqMan® technology (Applied 
Biosystems) and the LightCycler 480 qPCR instrument (Roche, 
Copenhagen, Denmark). Predesigned AMH, FSHR, AR, and 
CYP19a1 TaqMan® Gene Expression Assays, as well as the 
Endogenous Control Assays for human β-actin and glyceralde-
hyde 3-phosphatdehydrogenase (GAPDH) were purchased from 
Applied Biosystems [Assay id no.: β-actin: #4326315E, GAPDH: 
#4333764F, AMH: #Hs00174915_m1, FSH-R: #Hs00174865_m1, 
AR: #Hs00171172_m1, and Cyp19a1 (aromatase): #Hs00903413]. 
Data were quantified according to the comparative CT method 
(LightCycler480 Software, Roche); expression levels are presented 
as 2-ΔCT normalized to GAPDH (20).
statistical analysis
Statistical analysis was performed using GraphPad Prism 6.07 
program (GraphPad Software, Inc., CA, USA). One-way analysis 
of variance (ANOVA) was used to determine the significant dif-
ferences in hormone levels and follicular content in relation to 
the follicular diameter of hSAFs, and mRNA gene expression of 
GC-specific substances in hSAF in relation to follicular diameter. 
Spearman’s rank correlation was used to evaluate correlations 
between various hormones in FF and between genes expressed 
in GC. A level of P < 0.05 was considered statistically significant.
resUlTs
The number of follicles aspirated per woman varied from 1 to 
13, with the vast majority having one or two follicles aspirated 
(Figure  1A). The diameter of follicles aspirated from women 
above the age of 15 years is depicted in Figure 1B. Follicles with 
diameters from 4 to 7 mm account for more than 80% of the all 
analyzed follicles.
Follicular content and concentrations of 
Peptide and steroid hormones
The intrafollicular concentration of inhibin-B showed a highly 
significant variation with follicular diameter showing peak 
4Kristensen et al. Hallmarks of hSAF Development
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concentrations around diameters of 9–11  mm. The follicular 
content of inhibin-B also showed a highly significant variation 
with follicular diameter with a peak at 11 mm and high flanking 
values in 10 and 12 mm follicles (Figure 2; Tables S1 and S2 in 
Supplementary Material).
Inhibin-A exhibited a peak at around 9–10  mm similar to 
inhibin-B, but inhibin-A was present in concentrations compris-
ing around 8–20% of that of inhibin-B with a relative concentra-
tion of inhibin-A increasing as the follicular diameter increased 
(3–11  mm). When the diameter exceeded 13  mm, the picture 
reversed and the concentration and content of inhibin-A exceeded 
that of inhibin-B (Figure 2; Tables S1 and S2 in Supplementary 
Material).
Both the concentration and the content of AMH showed a 
highly significant association with the follicular diameter with 
peak values at around a diameter of 8 mm (Figure 2; Tables S1 
and S2 in Supplementary Material). Noteworthy is the follicular 
content of inhibin-B, inhibin-A, and AMH (calculated in nano-
grams), which was in a similar order of magnitude comprising 
around 100–200  ng at peak levels with a little less inhibin-A. 
Despite the relative smooth curves based on the mean levels and 
mean content of the follicles, the variability in follicles with a 
given diameter was very high (Tables S1 and S2 in Supplementary 
Material). There was a highly significant negative association 
between the FF concentrations of AMH and inhibin-B irrespec-
tive of follicular diameter (Spearman rank sum test: N =  538; 
R = 0.46; P < 0.00001).
The intrafollicular concentrations of the four evaluated ster-
oids showed different associations with the follicular diameter. 
Androstenedione and testosterone were both relatively constant, 
but testosterone showed a peak at a follicular diameter of 10 mm 
(Figure  2). In contrast, estradiol starts to increase at around 
8–10 mm (Figure 2), coinciding with a reduction in intrafollicu-
lar AMH concentrations and GC expression (Figures 2 and 3). 
Progesterone remained relatively constant but ended with a steep 
increase in concentration at a follicular diameter of 11–12 mm 
(Figure 2). The association between the follicular diameter and 
the intrafollicular concentrations of follistatin and PAPP-A is also 
shown in Figure 2. PAPP-A showed a steep increase in the con-
centration starting with a follicular diameter of 8 mm, whereas 
follistatin was relatively constant with a drop in concentration at 
around 8–10 mm.
gene expression Profiles of selected 
genes
The mRNA expression profiles of GC showed that FSHR expres-
sion is highly dependent on the follicular diameter and decreases 
with increasing diameter (Figure  3). This contrasts CYP19 
mRNA expression that in parallel to the concentration of estra-
diol starts to increase at diameters of 8–10 mm (Figure 3). The 
AR mRNA expression in relation to follicular diameter showed 
a decreasing expression as the follicular diameter increase in 
close association with the FSHR expression (Figure  3). There 
was a highly significant association between mRNA expression 
of AR and FSHR (Spearman rank sum test: N = 310; R = 0.77; 
P <  0.00001). The AMH expression decreased with increasing 
follicular diameter as expected (Figure 3). As for the substances 
present in FF, the variability of the gene expression was massive 
in between individual follicles with similar diameter (Table S3 in 
Supplementary Material).
DiscUssiOn
Including data from almost 1,000 normal hSAF, the present 
study documented profound changes taking place in the average 
concentrations of multiple key FF hormones and GC-expressed 
genes in relation to follicular development. It is especially 
noticeable that for all the secreted hormones, major alterations 
in the intrafollicular concentrations emerge with diameters from 
around 8 to 11 mm (Figure 4). This corresponds to the follicular 
stage in which selection of the dominant follicle takes place in 
each individual menstrual cycle and demonstrates the dramatic 
changes that occur during the transition of follicles from the 
recruitable stage to the selected follicle destined to ovulate with 
a pronounced shift in steroidogenesis resulting in a massive syn-
thesis of estradiol/CYP19 (aromatase) and progesterone. Overall, 
this enforces the notion introduced by Yen and Jaffe (29) almost 
half a century ago, hormonal regulation of the follicular phase 
of the menstrual cycle differs in two periods during a first half 
lasting to around cycle day 7 and a second half starting from the 
day of follicle selection and until ovulation.
Furthermore, the current data not only corroborate and extend 
that regulation of ovarian steroidogenesis during the follicular 
phase of the menstrual cycle is governed by FSH and LH but also 
highlight that local TGF-β growth factors exert important parac-
rine and autocrine functions that act to secure the development of 
one competent follicle selected for ovulation per cycle.
The present study demonstrates that intrafollicular concentra-
tions of estradiol start to rise rapidly in the window of follicular 
selection (i.e., 8–11  mm) paralleled by concomitant increase 
in CYP19 mRNA expression. Several mechanisms are prob-
ably involved in this strong upregulation. First, inhibins become 
synthesized as a result of FSH stimulation. Thus, the follicle that 
secretes high amounts of inhibins probably also possesses high 
FSHR expression. So not only does FSH secure substrate for 
aromatization via inhibin and subsequent androgen synthesis 
but does also stimulate aromatase and LHR expression, which 
are essential for estradiol production during the second half of 
the follicular phase (5). Despite the high levels of FSH in first 
half of the follicular phase aromatase expression and estradiol 
production remain relatively low (30) as the FF data of the 
present study also suggest. This appears to be an effect of AMH 
which in the very high concentrations present in hSAF exert a 
negative effect on estradiol production (18, 22, 31). At follicular 
selection, the dominant follicle acquires strong aromatase expres-
sion and upregulate estradiol production, which to a large extent 
appears to be driven by decreasing levels of AMH (attenuating) 
and increasing levels of inhibins (augmenting). In this scenario, 
AMH and inhibins could be expected to be inversely associated, 
which indeed is the case in the present study and confirms an 
earlier study (22). This suggests that both AMH and inhibin-B 
are intimately associated and both involved in the regulation of 
follicular estradiol synthesis.
FigUre 2 | Continued
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FigUre 3 | Granulosa cell expression of selected genes in human small antral follicles. Graphs show relative expression levels of FSHR, CYP19a1, AR, and AMH in 
relation to follicular diameter. Values are presented as mean ± SEM. Statistically significant differences were observed in the mRNA expression levels of FSHR 
[analysis of variance (ANOVA); N = 315; P < 0.002] and AR (ANOVA; N = 316; P < 0.03), but not for CYP19a1 (ANOVA; N = 252; P > 0.10) and AMH (ANOVA; 
N = 277; P > 0.10). Specific numbers for the analyzed follicle groups divided according to follicular diameter are shown in Table S3 in Supplementary Material.
FigUre 2 | Intrafollicular content and concentrations of peptide and steroid hormones. Graphs show the follicular fluid concentrations of estradiol, progesterone, 
androstenedione, testosterone, inhibin B, inhibin A, AMH, PAPP-A, and follistatin, and follicular content in nanograms (bottom panel) of inhibin B, inhibin A, and AMH 
according to follicular diameter. Values are presented as mean ± SEM. Statistically significant differences were observed in intrafollicular hormone levels of estradiol 
[analysis of variance (ANOVA); N = 264; P < 0.001], androstenedione (ANOVA; N = 276; P < 0.03), progesterone (ANOVA; N = 267; P < 0.003), PAPPA (ANOVA; 
N = 96; P < 0.03), inhibin-B (ANOVA; N = 627; P < 0.002), inhibin-A (ANOVA; N = 258; P < 0.001), AMH (ANOVA; N = 655; P < 0.001), but not testosterone 
(ANOVA; N = 566; P > 0.10) and follistatin (ANOVA; N = 148; P > 0.10). Regarding follicular content (bottom panel), the intrafollicular contents of inhibin-B (ANOVA; 
N = 611; P < 0.001), inhibin-A (ANOVA; N = 258; P < 0.001), and AMH (ANOVA; N = 654; P < 0.001) were observed to be significantly different in relation to 
follicular diameter. Specific numbers for the analyzed follicle groups divided according to follicular diameter are shown in Tables S1 and S2 in Supplementary 
Material.
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In addition, IGF2 is also likely to play an important role in 
the regulation of estradiol synthesis by the selected follicle. The 
present study showed that the intrafollicular concentration of 
PAPP-A increased almost threefold in follicles with diameters 
increasing from 8 to 12  mm. Again, assuming that PAPP-A 
expression reflects IGF bioactivity (32–36), it is noteworthy 
that PAPP-A expression moves from the theca cells to the GC 
as the follicles become dominant (24, 34–36). The increased 
IGF activity may serve two purposes: first, the exceptional high 
proliferation of GC during the second half of the follicular phase 
probably requires a strong local signal especially since the FSHR 
expression becomes downregulated (21). Second, IGF2 on its 
own stimulates human GC estradiol synthesis (37–40), which has 
recently been shown with highly significant associations between 
PAPP-A activity in FF and estradiol concentrations in FF from 
different-sized follicles (24, 34).
It is surprising that FSHR expression per cell declines with fol-
licular diameter and is significantly reduced at follicular selection 
during the natural menstrual cycle, confirming an earlier study 
(21). When GC from preovulatory follicles prior to ovulation 
induction were challenged by similar concentrations of FSH 
and LH, aromatase in  vitro induction was clearly biggest after 
stimulation with LH, and in connection with ovarian stimula-
tion for infertility treatment it has been shown that just a modest 
addition of LH-like activity results in a pronounced augmenta-
tion of estradiol. Collectively suggesting that LH probably also 
plays a prominent role in stimulation of aromatase expression. 
Furthermore, it is likely that there is a redundancy between FSH 
and LH in induction of aromatase expression and that ovarian 
stimulation with exogenous FSH preparations overcomes a 
reduction in FSHR expression. Furthermore, as the present 
results are expressed as FSHR expression per cell, the collective 
follicular FSHR number may still increase because of the hectic 
proliferation of GC as the follicle enlarges.
The inhibitory effect of inhibins in concentrations of picograms 
per milliliter on pituitary FSH release is well recognized, but the 
FigUre 4 | Hallmarks of human small antral follicle development: 
implications for regulation of ovarian steroidogenesis and selection of the 
dominant follicle.
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importance of the simultaneous paracrine effect of inhibins in 
synergy with LH on theca cell androgen synthesis continues to be 
unrevealed in human ovaries. The intrafollicular concentration 
of inhibin-B plus inhibin-A remained relatively constant around 
100–120 ng/ml in follicles with diameters of 3–7 mm but doubled 
to 200–220 ng/ml and showed a peak in follicles with diameters of 
9–10 mm. Previous in vitro studies of human theca cells showed 
that inhibins act in synergy with LH to upregulate synthesis of 
androstenedione (8–11, 41–45). The maximal concentration 
of inhibins tested in these studies was 100  ng/ml. Indeed, the 
collective intrafollicular concentrations reach at least twice this 
concentration and make it conceivable that the theca cells actu-
ally are exposed to such high concentrations in vivo. Obviously, 
theca produced androstenedione requires further metabolism 
to testosterone and to diffuse to the follicular compartment to 
exert a true androgenic effect. In this context, it is noteworthy 
that intrafollicular concentrations of testosterone in parallel 
to intrafollicular inhibins also peak in follicles with diameters 
of around 9–11 mm in line with recent results showing strong 
significant associations between inhibin-B and androstenedione 
and testosterone in hSAFs (5). The intrafollicular testosterone 
concentrations exert a stimulatory effect on the GC expression 
of FSHR (19, 46, 47) and subsequently expression of LHR. 
Androgens act through the AR, and the notion is enforced by 
the highly significant association between FSHR and AR mRNA 
levels in GC from hSAFs of the present study (19). Thereby, the 
selected follicle on one side secures not only a sufficient substrate 
for a high estrogen production but also a sufficient FSHR expres-
sion, which in light of declining FSH levels is required to secure 
sufficient LHR expression to sustain ovulation. In fact, the shape 
of the FSHR and AR mRNA expression profile in relation to fol-
licular diameter is almost superimposable and suggests a close 
interrelationship.
It has also been reported that in humans especially IGF2 
augment theca cell-derived androgen production in synergy 
with LH [human (48–50), primate (51), and rats (11, 52, 53)]. It 
has previously been difficult to account for the biological activ-
ity of IGFs because there are several different binding proteins 
(i.e., IGFBP 1–6) inactivating IGF activity, proteases that specifi-
cally cleave different IGFBPs to release bound IGFs (i.e., PAPP-A 
and PAPP-A2), and furthermore specific proteins that inactivate 
the proteolytic activity of PAPP-A (i.e., stanniocalcin 1 and 2) 
(32, 34). On top of this complicated system for regulating IGF 
bioactivity, it appears that the presence of PAPP-A covalently 
linked to the cell membrane secures a local microenvironment 
where IGFs released after specific cleavage by PAPP-A have a 
possibility to activate IGF receptors and cause signal transduc-
tion (32). Collectively, however, several studies have now shown 
that concentrations of PAPP-A appear to be a good surrogate 
marker for the bioactivity of IGFs (32, 34). It has been shown that 
PAPP-A becomes expressed in the theca cells of hSAF moving to 
the GC as the follicle develops further (24). These results suggest 
a local production of IGFs that corroborate in vitro studies (11, 
48–52) that showed a synergistic effect of LH and IGFs on theca 
cell androgen production.
Collectively, these new data support the original hypothesis 
proposed by Hillier and coworkers in their landmark studies on 
human tissue in the early 1990s and place especially inhibin-B and 
IGF2 in a physiological context as important paracrine regulators 
augmenting steroid output by especially the selected follicle in the 
second half of the human follicular phase.
Both inhibins and IGFs themselves can independently stimu-
late androgen production in synergy with LH, but it appears that 
they utilize separate mechanisms. Inhibins are capable of enhanc-
ing the combined maximal stimulatory effect of LH and IGF1 
with an up to 10-fold higher androgen output in human theca 
cells in vitro (12, 43).
While inhibins augment theca cell androgen production, 
activins, in contrast, have been shown to exert the opposite effect 
and reduce androgen output via downregulating expression of 
CYP17 and 3β-hydroxy steroid dehydrogenase [human (12, 54), 
rat (9), bovine (55, 56), sheep (42, 44, 57)]. No specific receptors for 
inhibins have been identified and no corresponding second mes-
senger signaling pathway system identified. The affinity of activin 
for the activin type II receptor is around 10-fold higher than that 
of inhibins (58), but by binding to the membrane bound β-glycan, 
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inhibins augment interaction with the activin type II receptor and 
enhance its effect as an activin antagonist (6). In this context, it 
is interesting to notice that FF concentrations of inhibin-A start 
to surpass those of inhibin-B when follicles exceed a diameter of 
around 13–14 mm. In circulation, this is only observed close to 
ovulation when the effect of massive inhibin-B production in con-
nection with selection is being reduced and suggests that theca cell 
androgen production is maintained at a high level until ovulation.
Taken together, regulation of androgen production in hSAF 
is likely to involve an upregulation of LHR number via locally 
expressed PAPP-A, which leads to enhanced IGF2 activity that 
acts on the IGFR being expressed on theca cells (59). Independent 
of the IGF2 action, inhibins in FF of hSAF being present in high 
concentrations reduce a negative impact of activins and enhance 
the 17-hydroxylase/C17–20 lyase activity that further augments the 
androgen producing capacity.
In this context, it is noteworthy that LHR numbers have been 
shown to be a major determinant for hCG-induced steroidogenic 
output from cells during culture highlighting that LHR density 
is of importance for LH action (60). Therefore, the follicle where 
the surrounding theca cells respond with highest production of 
androgen is most likely to become the selected follicle destined to 
ovulate as recently described (5). The present data emphasize the 
exquisite sensitivity of theca cells to LH stimulation in combination 
with inhibins, IGFs, and potentially other locally produced growth 
factors in the regulation of ovarian steroidogenesis and function.
Collectively, a local amplification of thecal androgen produc-
tion by inhibins and IGF2 suggests a mechanism through which 
follicular dominance is acquired and maintained in human 
reproductive cycles.
A major limitation of the present study is the inability to dis-
tinguish between healthy follicles and follicles which have started 
to undergo atresia. A fraction of the follicles in this study have 
already become atretic to some degree (61), but will be saved by 
administration of exogenous FSH preparations. It is well-known 
that oocytes from a cohort of follicles as a result of exogenous FSH 
stimulation may result in several children pointing at a clear clini-
cal interest. The degree of atresia is likely to affect steroidogenesis 
and to what extent this affects the outcome measures as reported 
in the present study is unknown. This may reflect that the FF 
concentrations as reported in the present study show a massive 
range, often more than three orders of magnitude from one fol-
licle to the other, which, however, may not be linked to atresia 
but rather reflect other factors. Obviously, there is a whole range 
of methods to detect the rate of atresia, but the often very limited 
number of GC from each individual follicle does not allow for 
detailed analysis.
The present study has only addressed a limited number of 
albeit prominent TGF-β growth factors and their presence in FF 
from hSAF and their potential effect on ovarian steroidogenesis. 
Indeed, other TGF-β growth factors have been reported to affect 
ovarian steroidogenesis, and it is likely that regulation involves a 
number of other factors such as BMP 4, 6, and 7 (42, 54, 62, 63).
It is interesting to notice that a number of the mechanisms 
proposed to regulate ovarian steroidogenesis involve release of 
biological active substances in the vicinity of the cell membrane. 
Covalently coupled PAPP-A appears to cleave IGFBP to release 
IGFs close to the membrane bound receptor (33), and locally high 
concentrations of inhibins can attenuate even locally produced 
activin from interaction with its receptor are examples that may 
improve our understanding of how the fine-tuned hormonal 
regulation of ovarian steroidogenesis takes place in vivo.
In conclusion, the present study suggests that regulation of 
human ovarian steroidogenesis during the follicular phase differs 
between the first part of the follicular phase in which recruit-
ment takes place and the second half where development of the 
dominant follicle concomitant with a massive output of estradiol. 
Especially with follicular diameters of around 8–11 mm, regulation 
of steroid production change profoundly with significant impact 
from paracrine and autocrine regulation of TGF-β growth factors 
especially inhibins and activins that together with IGF2 via PAPP-A 
modulate and fine-tune the effects of FSH and LH in order to 
secure the development of one dominant follicle in each menstrual 
cycle. The pronounced effects of inhibin-B are noticeable acting 
both to reduce pituitary output of FSH, but also as a follicle derived 
signal to augment androgen production locally by the theca cells, 
which in turn upregulate FSHR mRNA expression that enables the 
dominant follicle to respond to the decreasing levels of FSH by 
having aromatase and LHR mRNA expression upregulated.
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